Seven Eight Capital LP Takes $785,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Seven Eight Capital LP acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,668 shares of the biotechnology company’s stock, valued at approximately $785,000.

Several other large investors also recently bought and sold shares of AXON. Vanguard Personalized Indexing Management LLC grew its stake in shares of Axon Enterprise by 7.8% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 6,354 shares of the biotechnology company’s stock worth $1,843,000 after acquiring an additional 462 shares during the period. Amalgamated Bank boosted its holdings in Axon Enterprise by 0.5% in the second quarter. Amalgamated Bank now owns 15,347 shares of the biotechnology company’s stock worth $4,516,000 after purchasing an additional 71 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. grew its position in Axon Enterprise by 11.2% in the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,112 shares of the biotechnology company’s stock worth $327,000 after purchasing an additional 112 shares during the period. SYSTM Wealth Solutions LLC raised its stake in Axon Enterprise by 86.1% during the 2nd quarter. SYSTM Wealth Solutions LLC now owns 3,844 shares of the biotechnology company’s stock valued at $1,131,000 after buying an additional 1,778 shares during the last quarter. Finally, Total Clarity Wealth Management Inc. lifted its holdings in shares of Axon Enterprise by 4.3% during the 2nd quarter. Total Clarity Wealth Management Inc. now owns 1,224 shares of the biotechnology company’s stock valued at $360,000 after buying an additional 50 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently commented on the company. Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, August 7th. Jefferies Financial Group initiated coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. JMP Securities upped their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Finally, Barclays lifted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

Get Our Latest Research Report on Axon Enterprise

Insider Transactions at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 317,981 shares of company stock valued at $115,662,734. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Trading Up 0.9 %

AXON stock opened at $393.29 on Friday. The company has a market capitalization of $29.72 billion, a price-to-earnings ratio of 115.00, a PEG ratio of 10.34 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $393.58. The business has a 50 day simple moving average of $348.04 and a two-hundred day simple moving average of $317.22.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise’s quarterly revenue was up 34.5% on a year-over-year basis. During the same period last year, the company posted $0.80 earnings per share. Research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.